Date |
Report No. |
Title |
Date Oct. 17, 2001 |
Report No. GAO-02-162T |
Title
United States General Accounting Office GAO Testimony
Before the Committee on Governmental Affairs, U.S. Senate For Release on Delivery Expected at 9:30 a.m., Wednesday, October 17, 2001 COMBATING TERRORISM Considerations for Investing Resources in Chemical and Biological Preparedness
Statement of Henry L. Hinton, Jr. Managing Director, Defense Capabilities and Management GAO-02-162T Mr. Chairman ... |
Date Oct. 10, 2001 |
Report No. GAO-02-149T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives For Release on Delivery Expected at 10:00 a.m. Wednesday, October 10, 2001 BIOTERRORISM Review of Public Health Preparedness Programs
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-02-149T Mr. Chairma... |
Date Oct. 9, 2001 |
Report No. GAO-02-141T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions, United States Senate For Release on Delivery Expected at 10:00 a.m. Tuesday, October 9, 2001 BIOTERRORISM Public Health and Medical Preparedness
Statement of Janet Heinrich Director, Health Care—Public Health Issues GAO-02-141T Mr. Chairman and Memb... |
Date Oct. 5, 2001 |
Report No. GAO-02-129T |
Title
United States General Accounting Office GAO Testimony
Before the Subcommittee on Government Efficiency, Financial Management, and Intergovernmental Relations, Committee on Government Reform, House of Representatives For Release on Delivery Expected at 10:00 a.m. Friday, October 5, 2001 BIOTERRORISM Coordination and Preparedness
Statement of Janet Heinrich Director, Health Care—Public Health Issu... |
Date Sept. 28, 2001 |
Report No. GAO-01-915 |
Title
United States General Accounting Office GAO
September 2001 Report to Congressional Committees BIOTERRORISM Federal Research and Preparedness Activities GAO-01-915 a Contents Letter
Results in Brief Background Departments and Agencies Reported a Variety of Actions and Funding for Research and Preparedness Activities Despite Efforts to Coordinate Federal Programs, Fragmentation Remains Despite Feder... |
Date Sept. 28, 2001 |
Report No. GAO-01-667 |
Title
United States General Accounting Office GAO
September 2001 Report to the Chairman, Subcommittee on Military Readiness, Committee on Armed Services, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Improved Risk Assessment and Inventory Management Are Needed GAO-01-667 Contents Letter
Results in Brief Background DOD’s Assessment Process Is Unreliable for Determining Risk to Military Opera... |
Date May 1, 2001 |
Report No. GAO-01-666T |
Title
United States General Accounting Office GAO
For Release on Delivery 2:00 p.m. Tuesday, May 1, 2001 Testimony
Before the Subcommittee on National Security, Veterans Affairs and International Relations, Committee on Government Reform, House of Representatives COMBATING TERRORISM Accountability Over Medical Supplies Needs Further Improvement
Statement of Linda M. Calbom Director, Financial Management... |
Date April 24, 2001 |
Report No. GAO-01-13 |
Title
United States General Accounting Office GAO
April 2001 Report to the Chairman, Subcommittee on National Security, Veterans’ Affairs, and International Relations, House Committee on Governmental Reform COALITION WARFARE Gulf War Allies Differed in Chemical and Biological Threats Identified and in Use of Defensive Measures GAO-01-13 Contents Letter Appendix I Major Chemical Warfare Agents and Thei... |
Date March 30, 2001 |
Report No. GAO-01-463 |
Title
United States General Accounting Office GAO
March 2001 Report to the Chairman of the Subcommittee on National Security, Veterans Affairs and International Relations, Committee on Government Reform, House of Representatives COMBATING TERRORISM Accountability Over Medical Supplies Needs Further Improvement GAO-01-463 Contents Letter Appendixes
Appendix I: Objective, Scope, and Methodology 3 30 32 38... |
Date Dec. 13, 2000 |
Report No. GAO-01-21 |
Title
United States General Accounting Office GAO
December 2000 Report to Congressional Requesters STATE DEPARTMENT Serious Problems in the Anthrax Vaccine Immunization Program GAO-01-21 United States General Accounting Office Washington, D.C. 20548 Le er t December 13, 2000 The Honorable Jesse A. Helms Chairman, Committee on Foreign Relations United States Senate The Honorable Benjamin A. Gilman Chairm... |
Date Nov. 30, 2000 |
Report No. GAO-01-14 |
Title
United States General Accounting Office GAO
November 2000 Report to Congressional Requesters COMBATING TERRORISM Federal Response Teams Provide Varied Capabilities; Opportunities Remain to Improve Coordination GAO-01-14 Contents Letter Appendixes
Appendix I: Appendix II: Compendium of Selected Federal Response Plans and Authorities Selected Information About Federal Chemical, Biological, Radiologi... |
Date Nov. 14, 2000 |
Report No. GAO-01-27 |
Title
United States General Accounting Office GAO
November 2000 Report to the Chairman, Committee on Armed Services, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Units Better Equipped, but Training and Readiness Reporting Problems Remain GAO-01-27 Contents Letter Appendixes
Appendix I: Individual Protective Equipment 3 22 23 27 Appendix II: Medical Decontamination Supplies Appendix III: Comm... |
Date Sept. 13, 2000 |
Report No. T-NSIAD-00-249 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, September 13, 2000 Testimony
Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives ARMS CONTROL Experience of U.S. Industry With Chemical Weapons Convention Inspections
Statement of Jack L. Brock, Jr. M... |
Date July 26, 2000 |
Report No. T-NSIAD-00-218 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, July 26, 2000 Testimony
Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives COMBATING TERRORISM Linking Threats to Strategies and Resources
Statement of Norman J. Rabkin, Director National Security Pr... |
Date May 26, 2000 |
Report No. NSIAD-00-97 |
Title
United States General Accounting Office GAO
May 2000 Report to the Chairman and Ranking Minority Member, Committee on Armed Services, House of Representatives WEAPONS OF MASS DESTRUCTION DOD’s Actions to Combat Weapons Use Should Be More Integrated and Focused GAO/NSIAD-00-97 Contents Letter Appendixes
Appendix I: Chronology of Major Counterproliferation Milestones 3 30 32 34 46 58 61 70 Appendi... |
Date May 24, 2000 |
Report No. T-NSIAD-00-180 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. May 24, 2000, Wednesday Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Governmental Reform, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Program Planning and Evaluation Should Follow Results Act Framework
Statement of Kwai-Ch... |
Date April 28, 2000 |
Report No. NSIAD-00-138 |
Title
United States General Accounting Office GAO
April 2000 Report to Congressional Requesters BIOLOGICAL WEAPONS Effort to Reduce Former Soviet Threat Offers Benefits, Poses New Risks GAO/NSIAD-00-138 Contents Letter Appendixes Figures
Appendix I: Comments From the Department of State 3 38 41 Appendix II: GAO Contacts and Staff Acknowledgments Figure 1: Large Aerosol Test Chamber at Russia’s State R... |
Date April 14, 2000 |
Report No. T-NSIAD-00-140 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., CDT Friday, April 14, 2000 Testimony
Before the Subcommittee on Personnel, Committee on Armed Services, U.S. Senate CONTRACT MANAGEMENT DOD’s Anthrax Vaccine Manufacturer Will Continue to Need Financial Assistance
Statement of David E. Cooper, Associate Director Defense Acquisition Issues National Security... |
Date April 6, 2000 |
Report No. T-NSIAD-00-145 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 2:00 p.m. Thursday, April 6, 2000 Testimony
Before the Subcommittee on Oversight, Investigations, and Emergency Management, Committee on Transportation and Infrastructure, House of Representatives COMBATING TERRORISM Issues in Managing Counterterrorist Programs
Statement of Norman J. Rabkin, Director National Security ... |
Date March 22, 2000 |
Report No. T-NSIAD-00-130 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. March 22, 2000, Wednesday Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Observations on Nonmedical Chemical and Biological R&D Programs
Statement of Kwai-Cheung... |
Date March 8, 2000 |
Report No. T-HEHS/AIMD-00-59 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m. Wednesday, Mar. 8, 2000 Testimony
Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives COMBATING TERRORISM Chemical and Biological Medical Supplies Are Poorly Managed
Statement of Cynthia A. Bascetta, Associate D... |
Date Feb. 2, 2000 |
Report No. T-NSIAD-00-79 |
Title
United States General Accounting Office GAO
For Release on Delivery Estimated at 10:00 a.m., EST Wednesday, February 2, 2000 Testimony
Before the Subcommittee on National Security, Veterans' Affairs, and International Relations, Committee on Government Reform, House of Representatives GULF WAR ILLNESSES Basic Questions Unanswered
Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluat... |
Date Jan. 6, 2000 |
Report No. NSIAD-00-32 |
Title
United States General Accounting Office GAO
January 2000 Report to the Chairman, Subcommittee on National Security, Veterans’ Affairs and International Relations, Committee on Governmental Reform, House of Representatives GULF WAR ILLNESSES Management Actions Needed to Answer Basic Research Questions GAO/NSIAD-00-32 Contents Letter Appendixes
Appendix I: Research Objectives Identified by the Res... |
Date Nov. 4, 1999 |
Report No. NSIAD-00-54R |
Title
United States General Accounting Washington, DC 20548 Office National Security and International Affairs Division B-284044 November 4, 1999 The Honorable Steve Buyer Chairman, Subcommittee on Military Personnel Committee on Armed Services House of Representatives Subject: Summary Vaccine of GAO’s Findinas on the Safetv and Efficacv of the Anthrax Dear Mr. Chairman: Concerns have been raised abou... |
Date Oct. 29, 1999 |
Report No. HEHS/AIMD-00-36 |
Title
United States General Accounting Office GAO
October 1999 Report to Congressional Committees COMBATING TERRORISM Chemical and Biological Medical Supplies Are Poorly Managed GAO/HEHS/AIMD-00-36 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-282839 October 29, 1999 The Honorable Arlen Specter, Chairman Committee on Veterans’ Affai... |
Date Oct. 27, 1999 |
Report No. RCED-00-3 |
Title
United States General Accounting Office GAO
October 1999 Report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate FOOD SAFETY Agencies Should Further Test Plans for Responding to Deliberate Contamination GAO/RCED-00-3 GAO United States General Accounting Office Washington, D.C. 20548 Resources, Community, and Economic Development Division B-2... |
Date Oct. 22, 1999 |
Report No. NSIAD-00-36 |
Title
United States General Accounting Office GAO
October 1999 Report to the Chairman and Ranking Minority Member, Committee on Veterans’ Affairs, U.S. Senate MEDICAL READINESS DOD Faces Challenges in Implementing Its Anthrax Vaccine Immunization Program GAO/NSIAD-00-36 Contents Letter Appendixes
Appendix I: Appendix II: Scope and Methodology Packaging and Shipping Protocol 3 38 41 43 48 53 54 Appendi... |
Date Oct. 20, 1999 |
Report No. T-NSIAD-00-49 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Wednesday, October 20, 1999 Testimony
Before the Subcommittees on Military Procurement and on Military Research and Development, Committee on Armed Services, House of Representatives CHEMICAL AND BIOLOGICAL DEFENSE Observations on Actions Taken to Protect Military Forces
Statement of Norman J. Rabkin, D... |
Date Oct. 20, 1999 |
Report No. T-NSIAD-00-50 |
Title
United States General Accounting Office GAO
For Release on Delivery at 10:30 a.m., EDT Wednesday, October 20, 1999 Testimony Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives COMBATING TERRORISM Observations on the Threat of Chemical and Biological Terrorism
Statement of Henry L. Hinton, Jr., Assist... |
Date Oct. 12, 1999 |
Report No. T-NSIAD-00-48 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., EDT Tuesday, October 12, 1999 Testimony
Before the Committee on Government Reform, House of Representatives ANTHRAX VACCINE Safety and Efficacy Issues
Statement of Kwai-Cheung Chan, Director, Special Studies and Evaluations, National Security and International Affairs Division GAO/T-NSIAD-00-48 Mr. Chairman ... |
Date Sept. 7, 1999 |
Report No. NSIAD-99-163 |
Title
United States General Accounting Office GAO
September 1999 Report to Congressional Requesters COMBATING TERRORISM Need for Comprehensive Threat and Risk Assessments of Chemical and Biological Attacks GAO/NSIAD-99-163 United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-282772 Letter September 14, 1999 The Honorable Arlen Specter Chai... |
Date Aug. 16, 1999 |
Report No. NSIAD-99-160 |
Title
United States General Accounting Office GAO
August 1999 Report to Congressional Requesters CHEMICAL AND BIOLOGICAL DEFENSE Coordination of Nonmedical Chemical and Biological R&D Programs GAO/NSIAD-99-160 United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-282700 Letter August 16, 1999 The Honorable Robert C. Byrd Ranking Minority Me... |
Date Aug. 16, 1999 |
Report No. NSIAD-99-159 |
Title
United States General Accounting Office GAO
August 1999 Report to Congressional Requesters CHEMICAL AND BIOLOGICAL DEFENSE Program Planning and Evaluation Should Follow Results Act Framework GAO/NSIAD-99-159 United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-282699 Letter August 16, 1999 The Honorable Robert C. Byrd Ranking Minorit... |
Date July 21, 1999 |
Report No. T-NSIAD-99-226 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00, a.m., EDT Wednesday, July 21, 1999 Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives MEDICAL READINESS Issues Concerning the Anthrax Vaccine
Statement of Kwai-Cheung Chan, Director Special Studies and... |
Date July 13, 1999 |
Report No. NSIAD-99-219R |
Title
GAO United States General Accounting Office Washington, D.C. 20548 National Security and International AfTairs Division B-279127 July 13,1999 The Honorable Warren B. Rudman Chairman Presidential Special Oversight Board for Department of Defense Investigations of Gulf War Chemical and Biolog&al Incidents Subject: Gulf War Illnesses: Evaluation of DOD’s Investigative Processes Dear Mr. Chairman We... |
Date June 30, 1999 |
Report No. T-NSIAD-99-214 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EDT Wednesday, June 30, 1999 Testimony
Before the Subcommittee on National Security, Veterans Affairs, and International Relations, Committee on Government Reform, House of Representatives CONTRACT MANAGEMENT Observations on DOD’s Financial Relationship With the Anthrax Vaccine Manufacturer
Statement of L... |
Date June 9, 1999 |
Report No. T-NSIAD-99-181 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 2:00 p.m., EDT Wednesday, June 9, 1999 Testimony
Before the Subcommittee on Oversight, Investigations, and Emergency Management, Committee on Transportation and Infrastructure, House of Representatives COMBATING TERRORISM Observations on Growth in Federal Programs
Statement of Mark E. Gebicke, Director, National Securi... |
Date April 29, 1999 |
Report No. T-NSIAD-99-148 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EST Thursday, April 29, 1999 Testimony
Before the Subcommittee on National Security, Veterans’ Affairs, and International Relations, Committee on Government Reform, House of Representatives MEDICAL READINESS Safety and Efficacy of the Anthrax Vaccine
Statement of Kwai-Cheung Chan, Director, Special Studie... |
Date March 16, 1999 |
Report No. T-NSIAD-99-112 |
Title
GAO
For Release on Delivery Expected at 9:30 a.m., EST Tuesday, March 16, 1999 United States General Accounting Office Testimony Before the Committee on Veterans Affairs and the Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Committee on Appropriations, U.S. Senate COMBATING TERRORISM Observations on Biological Terrorism and Public Health Initiatives
Statement ... |
Date Feb. 26, 1999 |
Report No. NSIAD-99-59 |
Title
United States General Accounting Office GAO
February 1999 Report to the Honorable Lane Evans, Ranking Minority Member, Committee on Veterans Affairs, House of Representatives GULF WAR ILLNESSES Procedural and Reporting Improvements Are Needed in DOD’s Investigative Processes GAO/NSIAD-99-59 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Aff... |
Date Sept. 23, 1998 |
Report No. NSIAD-98-228 |
Title
United States General Accounting Office GAO
September 1998 Report to Congressional Requesters CHEMICAL WEAPONS DOD Does Not Have a Strategy to Address Low-Level Exposures GAO/NSIAD-98-228 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-280551 September 23, 1998 The Honorable Robert C. Byrd Ranking Minority Member Committee o... |
Date Aug. 19, 1998 |
Report No. HEHS-98-197 |
Title
United States General Accounting Office GAO
August 1998 Report to Congressional Requesters VA HEALTH CARE Better Integration of Services Could Improve Gulf War Veterans’ Care GAO/HEHS-98-197 GAO United States General Accounting Office Washington, D.C. 20548 Health, Education, and Human Services Division B-278641 August 19, 1998 The Honorable Cliff Stearns Chairman, Subcommittee on Health Committ... |
Date Aug. 18, 1998 |
Report No. NSIAD-98-214 |
Title
United States General Accounting Office GAO
August 1998 Report to the Honorable Rick Santorum, U.S. Senate CHEMICAL AND BIOLOGICAL DEFENSE DOD’s Evaluation of Improved Garment Materials GAO/NSIAD-98-214 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-279587 August 18, 1998 The Honorable Rick Santorum United States Senate D... |
Date Aug. 10, 1998 |
Report No. NSIAD-98-170R |
Title
X0 United States General Accounting Office Washington, D.C. 20548 Ntitional Security and International Affairs Division B-280539 August 10, 1998 The Honorable Arlen Specter Chairman, Committee on Veterans Affairs United States Senate The Honorable John D. Rockefeller IV Ranking Minority Member Committee on Veterans Affairs United States Senate Subject: Role of the Persian Gulf Veterans’ Coordina... |
Date March 17, 1998 |
Report No. T-NSIAD-98-83 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EST Tuesday, March 17, 1998 Testimony
Before the Committee on Veterans’ Affairs, U.S. Senate CHEMICAL AND BIOLOGICAL DEFENSE Observations on DOD’s Plans To Protect U.S. Forces
Statement of Mark E. Gebicke, Director, Military Operations and Capabilities Issues, National Security and International Affairs... |
Date March 3, 1998 |
Report No. NSIAD-98-89 |
Title
United States General Accounting Office GAO
March 1998 Report to the Chairman, Subcommittee on Human Resources, Committee on Government Reform and Oversight, House of Representatives GULF WAR VETERANS Incidence of Tumors Cannot Be Reliably Determined From Available Data GAO/NSIAD-98-89 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Di... |
Date Feb. 24, 1998 |
Report No. T-NSIAD-98-104 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 10:00 a.m., EST Tuesday, February 24, 1998 Testimony
Before the Subcommittee on Human Resources, Committee on Government Reform and Oversight, House of Representatives GULF WAR ILLNESSES Federal Research Strategy Needs Reexamination
Statement of Donna Heivilin, Director of Planning and Reporting, National Security and ... |
Date Feb. 5, 1998 |
Report No. T-NSIAD-98-88 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 1:00 p.m., EDT Thursday, February 5, 1998 Testimony
Before the Committee on Veterans Affairs, House of Representatives GULF WAR ILLNESSES Research, Clinical Monitoring, and Medical Surveillance
Statement of Donna Heivilin, Director of Planning and Reporting, National Security and International Affairs Division GAO/T-NS... |
Date Oct. 15, 1997 |
Report No. NSIAD-98-27 |
Title
United States General Accounting Office GAO
October 1997 Report to the Ranking Minority Member, Committee on Veterans’ Affairs, House of Representatives GULF WAR ILLNESSES Public and Private Efforts Relating to Exposures of U.S. Personnel to Chemical Agents GAO/NSIAD-98-27 GAO United States General Accounting Office Washington, D.C. 20548 National Security and International Affairs Division B-27... |
Date June 25, 1997 |
Report No. T-NSIAD-97-191 |
Title
United States General Accounting Office GAO
For Release on Delivery Expected at 9:30 a.m., EDT Wednesday, June 25, 1997 Testimony
Before the Committee on Veterans Affairs, U.S. Senate GULF WAR ILLNESSES Reexamination of Research Emphasis and Improved Monitoring of Clinical Progress Needed
Statement of Donna Heivilin, Director of Planning and Reporting, National Security and International Affairs D... |